China Isotope & Radiation Corporation announced that on 16 September 2022, the Board has resolved to appoint Mr. Dai Shuquan as the vice chairman of the third session of the Board. On the same day, the Board has also resolved to appoint: Mr. Chen Shoulei as a member of the Audit and Risk Management Committee under the Board; Mr. Wang Suohui as the chairman of the Strategy Committee under the Board, and Mr. Xu Hongchao and Mr. Dai Shuquan as members; and Mr. Wang Suohui as the chairman of the Legal Affairs Committee under the Board, and Mr. Chen Shoulei as a member. The terms of office of the above Vice Chairman, Board committee members and chairman start on the date hereof and end upon the expiry of the term of the third session of the Board, renewable upon re-election.
China Isotope & Radiation Corporation
Equities
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.02 HKD | -4.01% | -1.78% | -17.51% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.51% | 471M | |
-6.51% | 12.23B | |
-3.86% | 8.17B | |
+6.63% | 5.78B | |
+32.69% | 5.74B | |
-7.35% | 4.24B | |
-56.20% | 2.97B | |
+13.62% | 2.73B | |
-4.06% | 2.38B | |
+30.20% | 2.26B |
- Stock Market
- Equities
- 1763 Stock
- News China Isotope & Radiation Corporation
- China Isotope & Radiation Corporation Announces Board and Committee Changes